| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0006 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0006 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
| mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
0.0007 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.0008 |